82
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Immunoglobulin heavy chain V-D-J gene rearrangement and mutational status in Uruguayan patients with chronic lymphocytic leukemia

, , , , , , & show all
Pages 2070-2078 | Received 08 Jun 2010, Accepted 04 Sep 2010, Published online: 07 Oct 2010

References

  • Dighiero G, Hamblin TJ. Chronic lymphocytic leukaemia. Lancet 2008;371:1017–1029.
  • Surveillance Epidemiology and End Results Cancer Statistics [Internet]. National Cancer Institute [Accessed 4 June 2009.] Available from: http://seer.cancer.gov/statfacts/html/clyl.html
  • Shvidel L, Shtarlid M, Klepfish A, Sigler E, Berrebi A. Epidemiology and ethnic aspects of B cell chronic lymphocytic leukemia in Israel. Leukemia 1998;12:1612–1617.
  • Tamura K, Sawada H, Izumi Y, et al Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol 2001;67:152–157.
  • Ruiz-Argüelles GJ, Velázquez BM, Apreza-Molina MG, Pérez-Romano B, Ruiz-Reyes G, Ruiz-Argüelles A. Chronic lymphocytic leukemia is infrequent in Mexican mestizos. Int J Hematol 1999;69:253–255.
  • Damle RN, Wasil T, Fais F, et al Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840–1847.
  • Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848–1854.
  • Maloum K, Davi F, Merle-Béral H, et al Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000;96:377–379.
  • Schroeder HW Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 1994;15:288–294.
  • Fais F, Ghiotto F, Hashimoto S, et al Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515–1525.
  • Duke VM, Gandini D, Sherrington PD, et al VH gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Haematologica 2003;88:1259–1271.
  • Guarini A, Gaidano G, Mauro FR, et al Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features. Blood 2003;102:1035–1041.
  • Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 2004;103:4389–4395.
  • Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003;21:841–894.
  • Ghiotto F, Fais F, Valetto A, et al Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 2004;113:1008–1016.
  • Kolar GR, Capra JD. Ig V region restrictions in human chronic lymphocytic leukemia suggest some cases have a common origin. J Clin Invest 2004;113:952–954.
  • Ghia P, Stamatopoulos K, Belessi C, et al Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. Blood 2005;105:1678–1685.
  • Tobin G, Thunberg U, Karlsson K, et al Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 2004;104:2879–2885.
  • Widhopf GF II, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 2004;104:2499–2504.
  • Chen L, Zhang Y, Zheng W, et al Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia. Leuk Res 2008;32:1491–1498.
  • Koiso H, Yamane A, Mitsui T, et al Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia. Leuk Res 2006;30:272–276.
  • Hojjat Farsangi M, Jeddi-Tehrani M, Sharifian RA, et al Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia. Leuk Lymphoma 2007;48:109–116.
  • Hojjat-Farsangi M, Jeddi-Tehrani M, Razavi SM, et al Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia. Cancer Sci 2009;100:2346–2353.
  • Mauerer K, Zahrieh D, Gorgun G, et al Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukemia. Br J Haematol 2005;129:499–510.
  • Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 1997;158:235–246.
  • Widhopf GF II, Kipps TJ. Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 2001;166:95–102.
  • Potter KN, Orchard J, Critchley E, Mockridge CI, Jose A, Stevenson FK. Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. Blood 2003;101:3082–3084.
  • Pimentel BJ, Stefanoff CG, Santos Moreira A, Seuánez HN, Renault Zalcberg I. Use of VH, D and JH immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL). Genet Mol Biol 2008;31:643–648.
  • Sans M. Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol 2000;72:155–177.
  • Hidalgo PC, Bengochea M, Abilleira D, Cabrera A, Alvarez I. Genetic admixture estimate in the Uruguayan population based on the loci LDLR, GYPA, HBGG, GC and D7S8. Int J Hum Genet 2005;5:217–222.
  • Moro I, Foren L, Guillermo C, Borelli G, Pierri S, Gabús R. Primer registro nacional de leucemias. Paper presented at XI Uruguayan Hematology Congress, 19–21 November 2009. Punta del Este, Uruguay.
  • Hallek M, Cheson BD, Catovsky D, et al Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446–5456.
  • Binet JL, Lepoprier M, Dighiero G, et al A clinical staging system for chronic lymphocytic leukemia: prognostic significance. Cancer 1977;40:855–864.
  • Comczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
  • Pritsch O, Magnac C, Dumas G, Egile C, Dighiero G. V gene usage by seven hybrids derived from CD5 + B cell chronic lymphocytic leukemia and displaying autoantibody activity. Blood 1993;82:3103–3112.
  • Maniatis T, Fritsch E, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratories; 1982. p 545.
  • Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008;36:W503–W508.
  • Stamatopoulos K, Belessi C, Moreno C, et al Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 2007;109:259–270.
  • Murray F, Darzentas N, Hadzidimitriou A, et al Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 2008;111:1524–1533.
  • Bomben R, Dal Bo M, Capello D, et al Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 2009;144:492–506.
  • Chenna R, Sugawara H, Koike T, et al Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res 2003;31:3497–3500.
  • Matsuda F, Ishii K, Bourvagnet P, et al The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J Exp Med 1998;188:2151–2162.
  • Tobin G, Soderberg O, Thunberg U, Rosenquist R. V(H)3-21 gene usage in chronic lymphocytic leukemia-characterization of a new subgroup with distinct molecular features and poor survival. Leuk Lymphoma 2004;45:221–228.
  • Donisi PM, Di Lorenzo N, Riccardi M, et al Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a northeastern region of Italy. Diagn Mol Pathol 2006;15:206–215.
  • Pritsch O, Troussard X, Magnac C, et al VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol 1999;107:616–624.
  • Brezinschek HP, Foster SJ, Brezinschek RI, Dörner T, Domiati-Saad R, Lipsky PE. Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human CD5+/IgM+ and CD5-/IgM+ B cells. J Clin Invest 1997;99:2488–2501.
  • Oppezzo P, Vuillier F, Vasconcelos Y, et al Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 2003;101:4029–4032.
  • Messmer BT, Albesiano E, Messmer D, Chiorazzi N. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004;103:3490–3495.
  • Crespo M, Bosch F, Villamor N, et al ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003;348:1764–1775.
  • Irons RD, Le A, Bao L, et al Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns. Leuk Res 2009;33:1599–1603.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.